H.Res. 803 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, Oct 10, 2025
119th Congress
1st SessionH.Res. 803
1st SessionH.Res. 803
RESOLUTION
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
In the HouseNo vote yet
Sponsor: Rep. John W. Rose (R-TN-6) · Introduced Oct 10, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Oct 10, 2025: “Referred to the House Committee on Energy and Commerce.”